Is the mechanisms of fipronil-induced thyroid disruption specific of the rat: Re-evaluation of fipronil thyroid toxicity in sheep?

Toxicology Letters

Volumn 194, Issue 3, 2010, Pages 51-57

  Leghait, Julien ^a   Gayrard, Véronique ^a   Toutain, Pierre Louis ^a   Picard Hagen, Nicole ^a   Viguié, Catherine ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

Author keywords

Endocrine disruptor; Fipronil; Sheep; Thyroid toxicicity; Toxicokinetic

Indexed keywords

CYTOCHROME; FIPRONIL; LIOTHYRONINE; PHENAZONE; SULFONE; THYROID HORMONE; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; EUTHYROIDISM; EXPERIMENTAL ANIMAL; FEMALE; HORMONE BINDING; HORMONE BLOOD LEVEL; LONG TERM EXPOSURE; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SHEEP; SPECIES DIFFERENCE; THYROID DISEASE; THYROIDECTOMY;

ANIMALS; AREA UNDER CURVE; DISEASE MODELS, ANIMAL; FEMALE; INSECTICIDES; MALE; PYRAZOLES; RANDOM ALLOCATION; RATS; SHEEP; THYROID DISEASES; THYROID GLAND; THYROTROPIN; THYROXINE; TRIIODOTHYRONINE;

OVIS ARIES; RATTUS; TETRA;

EID: 77950857861     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.01.018     Document Type: Article

References (32)

1. Balani S.K., Zhu T., Yang T.J., Liu Z., He B., Lee F.W. Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys. Drug Metab. Dispos. 2002, 30:1059-1062.
2. Carcillo J.A., Doughty L., Kofos D., Frye R.F., Kaplan S.S., Sasser H., Burckart G.J. Cytochrome P450 mediated-drug metabolism is reduced in children with sepsis-induced multiple organ failure. Intensive Care Med. 2003, 29:980-984.
3. Davis P.J., Spaulding S.W., Gregerman R.I. The three thyroxine-binding proteins in rat serum: binding capacities and effects of binding inhibitors. Endocrinology 1970, 87:978-986.
4. De Pablo-Davila F., Miralles-Garcia J.M., Hernandez-Miguel E., Garcia Iglesias C., Corrales-Hernandez J.J., Castro del Pozo S. Study of the kinetics of the thyroid hormones and the peripheral conversion rate of thyroxine to triiodothyronine in acute renal insufficiency under experimental conditions. Horm. Metab. Res. 1980, 12:529-536.
5. DiStefano J.J., Feng D. Comparative aspects of the distribution, metabolism, and excretion of six iodothyronines in the rat. Endocrinology 1988, 123:2514-2525.
6. Ekins S., Reschly E.J., Hagey L.R., Krasowski M.D. Evolution of pharmacologic specificity in the pregnane X receptor. BMC Evol. Biol. 2008, 8:103.
7. Engel G., Hofmann U., Heidemann H., Cosme J., Eichelbaum M. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Clin. Pharmacol. Ther. 1996, 59:613-623.
8. Pharmacokinetics 1982, Marcel Dekker, Inc., New York, 494 pp. M. Gibaldi, D. Perrier (Eds.).
9. Hard G.C. Recent developments in the investigation of thyroid regulation and thyroid carcinogenesis. Environ. Health Perspect. 1998, 106:427-436.
10. Hurley P.M. Mode of carcinogenic action of pesticides inducing thyroid follicular cell tumors in rodents. Environ. Health Perspect. 1998, 106:437-445.
11. Kretschmer X.C., Baldwin W.S. CAR and PXR: xenosensors of endocrine disrupters?. Chem. Biol. Interact. 2005, 155:111-128.
12. Lanchote V.L., Ping W.C., Santos S.R. Influence of renal failure on cytochrome P450 activity in hypertensive patients using a " cocktail" of antipyrine and nifedipine. Eur. J. Clin. Pharmacol. 1996, 50:83-89.
13. Larsen P.R., Davies T.F., Schlumberger M.J., Hay I.D. Thyroid physiology and diagnostic evaluation of patients with thyroid disorders. Williams Textbook of Endocrinology 2002, pp. 331-365.
14. Leghait J., Gayrard V., Picard-Hagen N., Camp M., Perdu E., Toutain P.L., Viguie C. Fipronil-induced disruption of thyroid function in rats is mediated by increased total and free thyroxine clearances concomitantly to increased activity of hepatic enzymes. Toxicology 2008.
15. Leghait J., Gayrard V., Picard-Hagen N., Camp M., Perdu E., Toutain P.L., Viguie C. Fipronil-induced disruption of thyroid function in rats is mediated by increased total and free thyroxine clearances concomitantly to increased activity of hepatic enzymes. Toxicology 2009, 255:38-44.
16. Lemaire G., Mnif W., Pascussi J.M., Pillon A., Rabenoelina F., Fenet H., Gomez E., Casellas C., Nicolas J.C., Cavailles V., Duchesne M.J., Balaguer P. Identification of new human pregnane X receptor ligands among pesticides using a stable reporter cell system. Toxicol. Sci. 2006, 91:501-509.
17. Lincoln G.A., Almeida O.F., Klandorf H., Cunningham R.A. Hourly fluctuations in the blood levels of melatonin, prolactin, luteinizing hormone, follicle-stimulating hormone, testosterone, tri-iodothyronine, thyroxine and cortisol in rams under artificial photoperiods, and the effects of cranial sympathectomy. J. Endocrinol. 1982, 92:237-250.
18. Miralles-Garcia J.M., Garcia-Iglesias C., De Pablo-Davila F., Lanao J.M., Castro del Pozo S. Thyroxine an triiodothyronine kinetics and extrathyroidal peripheral conversion rate of thyroxine to triiodothyronine in healthy elderly humans. Horm. Metab. Res. 1981, 13:626-631.
19. Mohamed F., Senarathna L., Percy A., Abeyewardene M., Eaglesham G., Cheng R., Azher S., Hittarage A., Dissanayake W., Sheriff M.H., Davies W., Buckley N.A., Eddleston M. Acute human self-poisoning with the N-phenylpyrazole insecticide fipronil-a GABAA-gated chloride channel blocker. J. Toxicol. Clin. Toxicol. 2004, 42:955-963.
20. Refetoff S., Robin N.I., Fang V.S. Parameters of thyroid function in serum of 16 selected vertebrate species: a study of PBI, serum T4, free T4, and the pattern of T4 and T3 binding to serum proteins. Endocrinology 1970, 86:793-805.
21. Savu L., Vranckx R., Rouaze-Romet M., Maya M., Nunez E.A., Treton J., Flink I.L. A senescence up-regulated protein: the rat thyroxine-binding globulin (TBG). Biochim. Biophys. Acta 1991, 1097:19-22.
22. Schussler G.C. The thyroxine-binding proteins. Thyroid 2000, 10:141-149.
23. Sharer J.E., Wrighton S.A. Identification of the human hepatic cytochromes P450 involved in the in vitro oxidation of antipyrine. Drug Metab. Dispos. 1996, 24:487-494.
24. St Peter J.V., Awni W.M. Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites. Clin. Pharmacokinet. 1991, 20:50-65.
25. Sutherland R.L., Simpson-Morgan M.W. Effect of thyroidectomy on the concentration of plasma thyroxine-binding proteins in sheep. J. Endocrinol. 1974, 60:191-192.
26. Sutherland R.L., Simpson-Morgan M.W. The thyroxine-binding properties of serum proteins. A competitive binding technique employing sephadex G-25. J. Endocrinol. 1975, 65:319-332.
27. Tan S.W., Zoeller R.T. Integrating basic research on thyroid hormone action into screening and testing programs for thyroid disruptors. Crit. Rev. Toxicol. 2007, 37:5-10.
28. Tang J., Amin Usmani K., Hodgson E., Rose R.L. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam. Chem. Biol. Interact. 2004, 147:319-329.
29. Tingle C.C., Rother J.A., Dewhurst C.F., Lauer S., King W.J. Fipronil: environmental fate, ecotoxicology, and human health concerns. Rev. Environ. Contam. Toxicol. 2003, 176:1-66.
30. Tufenkji A.E., Alvinerie M., Pineau T., Boulard C., Galtier P. Incidence of a subclinical fascioliasis on antipyrine clearance and metabolite excretion in sheep. Xenobiotica 1988, 18:357-364.
31. Wu K.M., Farrelly J.G. Preclinical development of new drugs that enhance thyroid hormone metabolism and clearance: inadequacy of using rats as an animal model for predicting human risks in an IND and NDA. Am. J. Ther. 2006, 13:141-144.
32. Yokus B., Cakir D.U., Kanay Z., Gulten T., Uysal E. Effects of seasonal and physiological variations on the serum chemistry, vitamins and thyroid hormone concentrations in sheep. J. Vet. Med. A: Physiol. Pathol. Clin. Med. 2006, 53:271-276.